Uterine Cancer
IOCI Noida (International Oncology Cancer Institute), located at Sector 62, Noida, within Fortis Hospital, brings together specialists in surgical oncology, medical oncology, radiation oncology, and diagnostic testing.
The institute's Tumour Board meets to review complex cases and support personalised treatment decisions for each patient. For women across Noida and Greater Noida looking for the best uterine cancer hospital in Noida, a structured multidisciplinary evaluation can provide clarity and direction.
Uterine Cancer Treatment in Noida -Specialist Gynaecological Oncology Care
Uterine cancer develops in the tissues of the uterus, most commonly in the inner lining called the endometrium. It is one of the more frequently diagnosed gynaecological cancers in women, particularly after menopause. When recognised early, uterine cancer, particularly endometrial cancer, often responds well to treatment. For women in the Delhi NCR region seeking an endometrial cancer specialist in Noida, understanding the condition thoroughly is the right first step.
What Is Uterine Cancer?
Uterine cancer is broadly classified into two categories. Endometrial carcinoma, which accounts for the majority of cases, begins in the uterine lining. Uterine sarcoma, a less common form, originates in the uterine wall's muscle or connective tissue. Both require distinct diagnostic and therapeutic approaches, making specialist evaluation essential.
Types of Uterine Cancer
Understanding the specific type of uterine cancer is critical because each behaves differently and responds to different treatments.
Endometrioid Adenocarcinoma: The most common subtype, accounting for approximately 75–80% of all uterine cancers. It arises from the endometrial glands and is strongly associated with oestrogen excess. Most cases are diagnosed early and have a favourable prognosis with appropriate treatment.
Uterine Serous Carcinoma: A high-grade, aggressive subtype that accounts for a small proportion of cases but is responsible for a disproportionate number of uterine cancer deaths. It resembles ovarian serous carcinoma in behaviour and requires more intensive treatment, typically including chemotherapy even at early stages.
Clear Cell Carcinoma: Another high-grade subtype with an aggressive clinical course, requiring careful staging and multimodal treatment.
Uterine Carcinosarcoma (Malignant Mixed Müllerian Tumour): A rare but highly aggressive tumour containing both carcinoma and sarcoma elements. It behaves like a high-grade carcinoma and is treated accordingly with surgery and systemic chemotherapy.
Uterine Leiomyosarcoma: The most common uterine sarcoma, arising from the smooth muscle of the uterine wall (myometrium). It is biologically distinct from endometrial carcinomas and requires a different treatment approach.
Endometrial Stromal Sarcoma (ESS): Arises from the connective tissue of the endometrium. Low-grade ESS is relatively indolent; high-grade ESS is more aggressive.
The treating gynaecological oncologist will determine the specific subtype through biopsy and histopathological analysis, as the subtype directly shapes the treatment plan.
Early Symptoms of Uterine Cancer
The most notable symptom of uterine cancer is abnormal vaginal bleeding, particularly any bleeding after menopause. Other symptoms may include:
- Unusual discharge not related to menstrual periods.
- Pelvic pain or pressure
- Pain during intercourse
- Difficulty or pain when urinating
Because post-menopausal bleeding is distinctly abnormal, it should prompt gynaecological assessment without delay. Early-stage uterine cancer often produces recognisable symptoms, so timely consultation with the best gynaecological oncologist in Noida is especially important.
Who Is at Higher Risk?
Certain factors are associated with an increased risk of developing uterine cancer:
- Oestrogen dominance — prolonged exposure to oestrogen without adequate progesterone balance
- Obesity, which elevates circulating oestrogen levels
- Polycystic ovary syndrome (PCOS)
- Diabetes and hypertension
- Tamoxifen (used in breast cancer treatment)
- Family history of Lynch syndrome or hereditary colorectal cancer
- Late menopause or never having been pregnant
Risk factors increase the likelihood, not the certainty, of cancer developing.
Diagnosis at IOCI Noida
Diagnosis typically involves a combination of clinical history, pelvic examination, transvaginal ultrasound to assess endometrial thickness, and an endometrial biopsy, which provides definitive histological confirmation. In some cases, hysteroscopy may be performed to directly visualise the uterine cavity. Imaging, such as an MRI or CT scan, helps assess the extent of the disease and guide staging. Uterine cancer is staged using the FIGO (International Federation of Gynaecology and Obstetrics) system, which guides treatment planning based on tumour depth, lymph node status and spread.
Treatment Options — Surgery, Radiation and Hormonal Therapy
Uterine cancer surgery: the primary treatment for most stages. A total hysterectomy with bilateral salpingo-oophorectomy (removal of the uterus, cervix, fallopian tubes and ovaries) is the standard surgical approach. The uterine cancer surgery cost varies depending on stage, approach, and individual patient factors.
Following surgery, the treating oncology team may recommend:
Radiation Therapy: Either external beam radiation or internal radiation (brachytherapy) may be advised, particularly for intermediate or high-risk disease, to reduce the chance of local recurrence.
Hormonal Therapy: For certain low-grade endometrial cancers, hormonal treatment using progestins may be considered, particularly in women who wish to preserve fertility and have early-stage, well-differentiated disease. This approach requires careful specialist supervision.
Chemotherapy: For advanced or high-grade uterine cancers, systemic chemotherapy, often a combination of carboplatin and paclitaxel, may be recommended as part of the treatment plan.
Care at IOCI Noida
IOCI Noida (International Oncology Cancer Institute), located at Sector 62, Noida, within Fortis Hospital, brings together specialists in surgical oncology, medical oncology, radiation oncology, and diagnostic testing. The institute's Tumour Board meets to review complex cases and support personalised treatment decisions for each patient. For women across Noida and Greater Noida looking for the best uterine cancer hospital in Noida, a structured multidisciplinary evaluation can provide clarity and direction.
Frequently Asked Questions
1. What are the early symptoms of uterine cancer?
Abnormal or post-menopausal vaginal bleeding is the most common early symptom. Pelvic pain, unusual discharge, or discomfort during intercourse may also occur and should be evaluated promptly by a specialist.
2. How is uterine cancer diagnosed at IOCI Noida?
Diagnosis typically involves pelvic examination, transvaginal ultrasound, endometrial biopsy, and staging imaging such as MRI or CT scan, reviewed by the multidisciplinary oncology team using FIGO staging criteria.
3. What treatment options are available: surgery, radiation, or hormonal therapy?
Treatment may include surgical removal of the uterus, radiation therapy, hormonal therapy, or chemotherapy, depending on the cancer stage, grade, and individual patient health factors.
4. What is the survival rate for early-stage uterine cancer?
Early-stage endometrial cancer generally has a favourable prognosis when treated promptly. Outcomes depend on tumour grade, stage, histological subtype, and overall health. Consult your oncologist for personalised guidance.
5. Who is at higher risk of developing uterine cancer?
Women with obesity, oestrogen dominance, PCOS, diabetes, late menopause, Lynch syndrome, or prior tamoxifen use carry an elevated risk and may benefit from regular gynaecological monitoring and timely specialist review.




